Rezolute (RZLT) Interest Coverage Ratio (2012 - 2019)
Rezolute recorded quarterly Interest Coverage Ratio of 0.74 in Q2 2019, up 74.34% quarter-over-quarter from 2.89 in Q1 2019, and up 95.84% year-over-year from 0.38 in Q2 2018.
Rezolute's Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 0.74 for Q2 2019.
- In Q2 2019, Interest Coverage Ratio rose 95.84% year-over-year to 0.74; the TTM figure through Mar 2020 stood at 4.69 (down 20.21% YoY), while the FY2021 annual figure was 61.05, changed N/A from the prior year.
- Interest Coverage Ratio came in at 0.74 for Q2 2019 at Rezolute, up from 2.89 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.74 in Q2 2019 to a low of 39122.16 in Q4 2017.
- A 5-year average of 4067.51 and a median of 1390.15 in 2015 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio sank 237763.95% in 2015 and surged 99.99% in 2018, its largest moves.
- Rezolute's Interest Coverage Ratio stood at 2948.9 in 2015, then climbed by 18.71% to 2397.29 in 2016, then tumbled by 1531.93% to 39122.16 in 2017, then jumped by 99.99% to 2.45 in 2018, then soared by 69.81% to 0.74 in 2019.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.74, 2.89, and 2.45 for Q2 2019, Q1 2019, and Q4 2018 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -0.74 |
| Mar 31, 2019 | -2.89 |
| Dec 31, 2018 | -2.45 |
| Sep 30, 2018 | -2.81 |
| Jun 30, 2018 | -17.80 |
| Mar 31, 2018 | -92.83 |
| Dec 31, 2017 | -39,122.16 |
| Sep 30, 2016 | -2,397.29 |
| Jun 30, 2016 | -4,280.62 |
| Mar 31, 2016 | -3,250.63 |
| Dec 31, 2015 | -2,948.90 |
| Sep 30, 2015 | -2,045.69 |
| Jun 30, 2015 | -1,677.62 |
| Mar 31, 2015 | -1,102.68 |
| Dec 31, 2014 | -1,334.94 |
| Sep 30, 2014 | -4,470.24 |
| Jun 30, 2014 | -4,459.43 |
| Mar 31, 2014 | -0.46 |
| Dec 31, 2013 | -1.04 |
| Sep 30, 2013 | -4.25 |
| Jun 30, 2013 | -5.87 |
| Mar 31, 2013 | -22.31 |
| Dec 31, 2012 | -4.57 |
| Sep 30, 2012 | -5.18 |
| Jun 30, 2012 | -1.17 |
| Mar 31, 2012 | -1.03 |